Epipactis helleborine
Epipactis helleborine · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Epipactis helleborine, commonly known as the broad-leaved helleborine, is a resilient orchid species found in diverse woodland habitats. While this plant thrives in shaded environments, it shares no biological connection to the influenza A virus that affects human respiratory systems. Studying botanical life often provides a stark contrast to the microscopic mechanisms of viral infections. Understanding the distinction between plant biology and viral pathology is essential for scientific clarity. Therefore, this orchid remains a fascinating subject of study independent of any viral context.
- Synonyms
- Serapias Helleborine
- Common names
- Not available
- Family
- Orchidaceae
- Distribution
- Africa
- Plant Parts
- Not available
Classification
Common Names
Epipactis helleborine is a fascinating orchid species known by a variety of distinct regional names. In certain areas, it is referred to by the common name Bindallı Çiçeği. The plant also carries the descriptive titles of Brede en Duinwespenorchis and Brede wespenorchis. Furthermore, it is recognized in other contexts as the Breetbliedereg Harespelorchidee. Finally, the species is identified as the Breitblaettrige Stendelwurz, reflecting its diverse linguistic identity.
Sources: Catalogue of Life (COL)
Synonyms
Epipactis helleborine is a fascinating orchid species that is frequently discussed within botanical literature. In many taxonomic records, this plant is also identified by its synonym, Serapias helleborine. This overlapping nomenclature can sometimes cause confusion for researchers and enthusiasts navigating various botanical databases. Understanding these linguistic connections is essential for accurately classifying the plant's evolutionary lineage. Recognizing both names ensures that scientific communication remains consistent across different academic disciplines.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Epipactis helleborine is a distinctive species belonging to the vast kingdom Plantae. Within this kingdom, it is classified under the class Equisetopsida, marking its place among the flowering plants. It further falls into the order Asparagales, which helps define its evolutionary lineage. As a member of the Orchidaceae family, it exhibits the unique characteristics typical of true orchids. Ultimately, this plant is identified by its specific genus, Epipactis, which distinguishes it from other related species.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asparagales |
| Family | Orchidaceae |
| Genus | Epipactis |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Epipactis helleborine displays a broad and diverse geographical distribution spanning multiple continents. In Africa, this species can be found throughout Northern Africa, specifically within the territories of Algeria and Morocco. Its presence extends into the temperate regions of Asia, where it thrives across the Caucasus and the Transcaucasus. Furthermore, the plant is well-established in Central Asia, including parts of Kazakhstan. This wide range highlights the remarkable adaptability of the species across varied ecological landscapes.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Epipactis helleborine is a self-supporting herb that thrives in various woodland habitats. This plant typically maintains a modest stature, reaching a maximum height of approximately 0.8 m. However, individuals may also appear much smaller, with a minimum height of only 0.15 m. This variation in size reflects the adaptable nature of its growth form within its environment.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Conditions
Epipactis helleborine contains mannose-specific lectins that function as potent inhibitors against various viral pathogens in vitro. These plant-derived lectins demonstrate significant activity in treating human cytomegalovirus (CMV) and human immunodeficiency virus type 1 (HIV-1). Furthermore, the species shows marked effectiveness in combating influenza A virus and respiratory syncytial virus (RSV). Beyond direct viral inhibition, the lectins from this plant also treat syncytium formation between persistently HIV-1- and HIV-2-infected HUT-78 cells and CD4+ Molt/4 (clone 8) cells. This antiviral action is thought to occur at the level of virion fusion with the target cell.